loader image
Friday, March 29, 2024
69.7 F
McAllen
We Welcome your Press Release
- Advertisement -

Faculty studying role of pharmacists in opioid treatment

Translate to Spanish or other 102 languages!

Dr. Tamara Al Rawwad, PhD, MPH, an assistant professor in the UTRGV School of Social Work, and Dr. Adrian Sandoval, a practicing clinical pharmacist in the UTRGV School of Medicine, are collaborating on research involving "The Role of Community Pharmacists in the Provision of Medication-Assisted Treatment in Rio Grande Valley." (UTRGV Photos by Paul Chouy)
Dr. Tamara Al Rawwad, PhD, MPH, an assistant professor in the UTRGV School of Social Work, and Dr. Adrian Sandoval, a practicing clinical pharmacist in the UTRGV School of Medicine, are collaborating on research involving “The Role of Community Pharmacists in the Provision of Medication-Assisted Treatment in Rio Grande Valley.” (UTRGV Photos by Paul Chouy)

Mega Doctor News

- Advertisement -

By Karen Villarreal  

RIO GRANDE VALLEY, TEXAS – Two UTRGV faculty are researching why pharmacists haven’t played a much bigger role in federal efforts to combat nationwide misuse of opioids.

Dr. Tamara Al Rawwad, PhD, MPH, an assistant professor in the UTRGV School of Social Work, said that is changing, however, and the national strategy recommends that pharmacists – who are trained in medication management – be included on opioid abuse care teams.  

- Advertisement -

“Pharmacists are highly accessible medication experts who play a critical role in medication management, even if they don’t administer or prescribe it,” Al Rawwad said. “That’s so important with opioids because each case is unique, and the pharmacist has the best training to monitor side effects and educate patients. They have to be part of the team.”  

Care team members, including pharmacists themselves, aren’t all on the same page, though, about their role in managing medication for opioid use disorder (MOUD), with some pharmacists not comfortable counseling patients or dispensing these highly controlled substances at all despite new HHS guidelines that remove barriers for patients seeking recovery. 

“If we can identify why some pharmacists are not comfortable being part of the team, we can recommend policy changes and more education,” she said. 

PHARMACIST-INFORMED POLICY

- Advertisement -

Prior to Al Rawwad’s multidisciplinary study – “The Role of Community Pharmacists in the Provision of Medication-Assisted Treatment in Rio Grande Valley” – there has been no research into pharmacists’ perspectives on being part of opioid care teams that provide MOUD. 

Funded by UTRGV’s Internal Seed Research Program (ISRP), principal investigator Al Rawwad, who has a background in social work, public health and nursing, invited co-investigator Dr. Adrian Sandoval, a practicing clinical pharmacist in the UTRGV School of Medicine, to contribute his professional expertise and experience as a Valley native. Through this study, they will address the question of pharmacists’ attitudes to treating opioid misuse with MOUD, specifically focusing on those who practice in a rural area.  

“Their unique perspective in providing MOUD in an area that is culturally unique and historically underserved can possibly be extended to other rural areas,” Al Rawwad said. “With the input of local pharmacists, we can develop new guidelines tailored to meet the needs of diverse populations like the Valley’s, in addition to addressing gaps in prevention and treatment.”

 INCREASED ACCESS, INCREASED RISK 

Al Rawwad’s research contributes to a broad U.S. Dept. of Health and Human Services (DHS) study to combat opioid abuse and misuse by surveying community pharmacists in the Rio Grande Valley, a region considered to be at risk in the opioid crisis.

“Our proximity to Mexico – a destination for medical tourists and local residents alikedue to its more affordable prescription medications – means there is a lot of medication crossing the border that isn’t accounted for,” Al Rawwad said. “The fact that there is a huge amount of prescription drugs here, according to the U.S. Drug Enforcement Agency, puts the region at risk.”

Information on the way Valley pharmacists approach the opioid problem can be used to inform other at-risk regions by contributing to the national guidelines.

“It’s part of our efforts to expand education on substance use disorders among health professionals,” Al Rawwad said.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Publisher’s Word: Dr. Andrew W. Phillips and the Pioneering ECMO Program at DHR Health

Over the past year, the Rio Grande Valley has witnessed groundbreaking medical advancements, with DHR Health's Extracorporeal Membrane Oxygenation (ECMO) program leading the charge.

Dr. Andrew W. Phillips and the Pioneering ECMO Program at DHR Health

In a year marked by significant medical advancements within the Rio Grande Valley, DHR Health's celebration of the first anniversary of its Extracorporeal Membrane Oxygenation (ECMO) program stands out as state-of-the-art innovation and hope.

DHR Health Physicians, First in Texas to Offer Innovative Patient-Centric Treatment for Urge Urinary Incontinence

UUI, also known as urgent bladder leaks, is a common and often embarrassing problem.

Rene Luna, MD, celebrates 1,000th Robotic Surgical Procedure

Dr. Luna is considered one of the most experienced robotic surgery experts in Texas. 
- Advertisement -
×